1. Home
  2. > Healthcare
  3. > Health Services Market Trends
Nasal Polyposis - Epidemiology Forecast - 2032

Nasal Polyposis - Epidemiology Forecast - 2032

  • August 2022
  • 80 pages
  • ID: 6316460
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Nasal Polyposis - Epidemiology Forecast–2032’ report delivers an in-depth understanding of Nasal Polyposis, historical and forecasted epidemiology as well as Nasal Polyposis trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Nasal Polyposis Disease Understanding
Nasal Polyposis/Nasal polyps are small, benign drop-like growths appearing in the mucosa (lining tissues) of the nose and may block the nasal passageway. Nasal Polyposis tends to be present on both sides of the nasal cavity. Small Nasal Polyposis may not reflect any symptoms, but the larger growths or groups of Nasal Polyposis can block the nasal passages or lead to breathing problems, a lost sense of smell, and frequent infections. One-sided Nasal Polyposis may need to be investigated further as they might be malignant nasal or sinus tumors.
Nasal Polyposis are a subgroup of chronic rhinosinusitis. Chronic rhinosinusitis is a condition where the nasal cavity and sinuses are inflamed for more than 4 to 12 weeks. Patients suffering from chronic rhinosinusitis condition can be progressed into chronic rhinosinusitis with NP (CRSwNP), and chronic rhinosinusitis without NP (CRSsNP). Only a portion of chronic rhinosinusitis will develop Nasal Polyposis. CRSwNP is a potentially debilitating condition in adults that are characterized by inflammation of the nose and paranasal sinuses with the presence of Nasal Polyposis.
People with a history of chronic sinus infections, allergic rhinitis, asthma, cystic fibrosis, sensitivity to NSAIDs like ibuprofen and aspirin, and Churg–Strauss syndrome are more prone to getting Nasal Polyposis. Patients suffering from NP may experience chronic nasal congestion, running nose, postnasal drip, reduced sense of smell and taste, difficulty in breathing, pressure in the face or forehead area, snoring, sleep apnea, and others.
Nasal Polyposis Diagnosis
The diagnosis of Nasal Polyps is based on a combination of history, physical examination, and often a sinus CT scan. The history of nasal congestion and loss of smell points to Nasal Polyps. Nasal examination often by nasal endoscopy confirms the diagnosis of nasal polyps and distinguishes patients with CRSwNP from patients with CRSwNP. A sinus CT scan is helpful because it documents the extent of sinus disease.
Continued in the report…..
Nasal Polyposis Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by prevalent cases of chronic rhinosinusitis, diagnosed prevalent cases of chronic rhinosinusitis, diagnosed prevalent cases of Nasal Polyposis, and gender-specific diagnosed prevalent cases of Nasal Polyposis, the scenario of Nasal Polyposis in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2019 to 2032.
Nasal Polyposis Detailed Epidemiology Segmentation
• The total prevalent cases of chronic rhinosinusitis in the 7MM were found to be 69,550,461 cases in 2021. The prevalent cases of chronic rhinosinusitis are expected to rise by 2032.
• Among all the 7MM countries, the United States accounted for the highest diagnosed prevalent cases (8,691,874 cases) of chronic rhinosinusitis in 2021.
• In 2021, the total reported diagnosed prevalent cases of Nasal Polyposis in the 7MM countries were 4,358,603 cases which are expected to increase by 2032.
• In 2021, Germany accounted for the highest number of Nasal Polyposis diagnosed prevalent cases (617,716 cases), followed by the United Kingdom (435,157 cases) among EU-5 countries. In contrast, Spain accounted for the lowest number of Nasal Polyposis diagnosed prevalent cases in EU-5.
• As per the analysis, in Japan, most of the diagnosed prevalent cases of Nasal Polyposis were reported in males. In 2021, there were 111,545 diagnosed prevalent cases of Nasal Polyposis among males and 91,264 cases among females in Japan.

Scope of the Report
• The report covers a descriptive overview of Nasal Polyposis, explaining its symptoms, grading, pathophysiology, and various diagnostic approaches.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden of Nasal Polyposis.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM, a total number of prevalent cases of chronic rhinosinusitis, diagnosed prevalent cases of chronic rhinosinusitis, diagnosed prevalent cases of Nasal Polyposis, and gender-specific diagnosed prevalent cases of Nasal Polyposis.

Report Highlights
• 11-Year Forecast of Nasal Polyposis
• The 7MM Coverage
• Prevalent cases of chronic rhinosinusitis
• Diagnosed prevalent cases of chronic rhinosinusitis
• Diagnosed prevalent cases of Nasal Polyposis
• Gender-specific diagnosed prevalent cases of Nasal Polyposis

Key Questions Answered
• What are the disease risk and burdens of Nasal Polyposis?
• What is the historical Nasal Polyposis patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Nasal Polyposis at the 7MM level?
• What will be the growth opportunities across the 7MM concerning the patient population for Nasal Polyposis?
• Out of the above-mentioned countries, which country would have the highest diagnosed prevalent population of Nasal Polyposis during the forecast period (2022–2032)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2022–2032)?

Reasons to Buy
The Nasal Polyposis report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM Nasal Polyposis epidemiology forecast.
• The Nasal Polyposis epidemiology report and model were written and developed by Master’s and Ph.D. level epidemiologists.
• The Nasal Polyposis epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2019–2032

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast - 2032

  • $ 3950
  • September 2022
  • 140 pages

‘PCSK9 Inhibitors (PCSK9i) disease - Epidemiology Forecast to 2032’ report delivers an in-depth understanding of PCSK9i, historical and forecasted epidemiology in the 7MM, i.e., the United States, ...

  • Spain
  • France
  • Epidemiology
  • Cardiovascular Disease
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on